Insulin Glargine-yfgn
is interchangeable
with Lantus®.1
But what sets it apart is
the company behind it.
Insulin Glargine-yfgn is an insulin biosimilar that has demonstrated similarity to the reference biologic drug.1 What sets it apart is the company behind it.
Insulin Glargine-yfgn
is interchangeable
with Lantus®.1
But what sets it apart is
the company behind it.
Insulin Glargine-yfgn is interchangeable with Lantus®.1
But what sets it apart is the company behind it.
Insulin Glargine-yfgn
is interchangeable
with Lantus®.1
But what sets it apart is
the company behind it.
Insulin Glargine-yfgn
is interchangeable
with Lantus®.1
But what sets it apart is
the company behind it.
BIOCON BIOLOGICS IS FIGHTING FOR EVERYONE WHO NEEDS INSULIN
LOWERING THE COST
by leading the industry toward more affordable insulin options2
EXPANDING ACCESS IN THE US
with the launch of the first FDA-approved interchangeable biosimilar1
DELIVERING TO THOSE WHO NEED IT
supplying 5.25 billion doses of insulin globally to patients since 20043
EVERYTHING WE STAND FOR IS RIGHT HERE
A long-acting insulin biosimilar interchangeable with Lantus1,4,5
Similar efficacy, immunogenicity, and safety profiles1,4,5
Similar prefilled pen with no dosing differences1,4,5
RELIABLE PATIENT SUPPORT
Savings Card Program*
- Eligible commercially insured patients may pay as little as $0 per 30-day prescription, subject to a maximum savings of $65 per 30-day prescription.
- For questions regarding the Insulin Glargine-yfgn injection Savings Card Program, call 1-800-657-7613 Monday-Friday 8 AM-8 PM ET
*Eligibility restrictions apply. Not valid for uninsured patients or patients who are covered by a state- or federally funded healthcare program. Please see full terms and conditions here.
Urgent Need State Insulin Program‡
The Urgent Need State Insulin Program allows eligible patients who are in urgent need of insulin to receive a one-time, 30-day supply of Insulin Glargine-yfgn injection at their pharmacy. Voucher must be requested by a pharmacist.
‡Eligibility and restrictions apply as required by the applicable State Insulin Affordability/Safety Net Program law.
Trial Voucher Program†
<The Trial Voucher Program offers eligible patients a voucher for a free trial of 5 pens or 2 vials of either insulin product.
- Voucher must be requested by a healthcare professional
- A valid prescription must accompany the voucher>
FRIENDLY INJECTION ASSISTANCE
There’s a lot for patients to learn about injecting any insulin. But Insulin Glargine-yfgn has got your back. Our informative injection video walks patients through every step of the process—so they can learn on their own time, at their own pace.
Insulin Glargine-yfgn Prefilled Injector Pen
Click here for Instructions for Use.
Insulin Glargine-yfgn
10 mL Vial
(100 units/mL, U-100)
Click here for Instructions for Use.
Insulin Glargine-yfgn Prefilled Injector Pen
Click here for Instructions for Use.
Insulin Glargine-yfgn 10 mL Vial (100 units/mL, U-100)
Click here for Instructions for Use.
ROBUST BIOSIMILARITY DATA
- In randomized, open-label, Phase 3 trials conducted in patients with type 1 and type 2 diabetes, Insulin Glargine-yfgn and Lantus demonstrated highly similar results regarding changes in A1c and FPG from baseline6,7
- An additional study showed that switching patients between Insulin Glargine-yfgn and Lantus resulted in equivalent efficacy and comparable safety compared to patients receiving only Lantus8
FPG=fasting plasma glucose.
All insulin companies are not the same.
LOOK FOR THE ONE WHO,S BEEN STANDING WITH YOU ALL ALONG
Have a representative contact you with additional information (such as a leave behind or product brochure).
*Required fields.